Connecting you to content on EBSCOhost

Works matching AU Adamczyk, Robert

Results: 6

1

Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART‐FID.

Published in:

European Journal of Heart Failure, 2025, v. 27, n. 5, p. 872, doi. 10.1002/ejhf.3348

By:

Nouhravesh, Nina;
Garg, Jyotsna;
Rockhold, Frank W.;
De Pasquale, Carmine G.;
O'Meara, Eileen;
Lewis, Gregory D.;
Butler, Javed;
Harrington, Josephine;
Ezekowitz, Justin A.;
Ponikowski, Piotr;
Troughton, Richard W.;
Wong, Yee Weng;
Blackman, Nicole;
Numan, Syed;
Adamczyk, Robert;
Hernandez, Adrian F.;
Mentz, Robert J.

Publication type:

Article

2

The pharmacokinetics of peginterferon lambda-1a following single dose administration to subjects with impaired renal function.

Published in:

British Journal of Clinical Pharmacology, 2015, v. 80, n. 3, p. 515, doi. 10.1111/bcp.12634

By:

Hruska, Matthew W.;
Adamczyk, Robert;
Colston, Elizabeth;
Hesney, Michael;
Stonier, Michele;
Myler, Heather;
Bertz, Richard

Publication type:

Article

3

Safety, pharmacokinetics, and pharmacodynamics of BMS-986142, a novel reversible BTK inhibitor, in healthy participants.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 6, p. 689, doi. 10.1007/s00228-017-2226-2

By:

Lee, Sun;
Xing, Jun;
Catlett, Ian;
Adamczyk, Robert;
Griffies, Amber;
Liu, Ang;
Murthy, Bindu;
Nowak, Miroslawa

Publication type:

Article

4

Incorrect Correct.

Published in:

2016

By:

Adamczyk-Haswell, Peter Robert

Publication type:

Letter to the Editor

5

A Pooled Analysis of Pharmacokinetic Variability Information for Common Probe Substrates Used in Drug-Drug Interaction Studies.

Published in:

Pharmacology, 2018, v. 101, n. 3/4, p. 170, doi. 10.1159/000485516

By:

He, Chunsheng;
Griffies, Amber;
Liu, Xuan;
Adamczyk, Robert;
Huang, Shu-Pang

Publication type:

Article

6

An Open-Label Investigation into Drug-Drug Interactions Between Multiple Doses of Daclatasvir and Single-Dose Cyclosporine or Tacrolimus in Healthy Subjects.

Published in:

Clinical Drug Investigation, 2015, v. 35, n. 5, p. 281, doi. 10.1007/s40261-015-0279-5

By:

Bifano, Marc;
Adamczyk, Robert;
Hwang, Carey;
Kandoussi, Hamza;
Marion, Alan;
Bertz, Richard

Publication type:

Article